Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

167 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Preliminary safety and efficacy profile of prucalopride in the treatment of systemic sclerosis (SSc)-related intestinal involvement: results from the open label cross-over PROGASS study.
Vigone B, Caronni M, Severino A, Bellocchi C, Baldassarri AR, Fraquelli M, Montanelli G, Santaniello A, Beretta L. Vigone B, et al. Among authors: severino a. Arthritis Res Ther. 2017 Jun 20;19(1):145. doi: 10.1186/s13075-017-1340-y. Arthritis Res Ther. 2017. PMID: 28633671 Free PMC article. Clinical Trial.
Pulmonary and extra-pulmonary effects of lung transplantation in an Italian cohort of patients with systemic sclerosis.
Iannone C, Pellico MR, Morlacchi LC, Rossetti V, Vicenzi M, Beretta L, Severino A, Airò P, Cacciapaglia F, Codullo V, Faggioli P, Iagnocco A, Meloni F, Mercante L, Saracco M, Stano S, Zaccara E, Minniti A, Cavalli S, Trignani G, Blasi F, Nosotti M, Boffini M, Caporali R, Del Papa N. Iannone C, et al. Among authors: severino a. Rheumatology (Oxford). 2024 Sep 19:keae479. doi: 10.1093/rheumatology/keae479. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 39298492
Anti-RNPC-3 antibody predicts poor prognosis in patients with interstitial lung disease associated to systemic sclerosis.
Callejas-Moraga EL, Guillén-Del-Castillo A, Perurena-Prieto J, Sanz-Martínez MT, Fonollosa-Pla V, Lorite-Gomez K, Severino A, Bellocchi C, Beretta L, Mahler M, Simeón-Aznar CP. Callejas-Moraga EL, et al. Among authors: severino a. Rheumatology (Oxford). 2021 Dec 24;61(1):154-162. doi: 10.1093/rheumatology/keab279. Rheumatology (Oxford). 2021. PMID: 33742673
The interferon type I signature is present in systemic sclerosis before overt fibrosis and might contribute to its pathogenesis through high BAFF gene expression and high collagen synthesis.
Brkic Z, van Bon L, Cossu M, van Helden-Meeuwsen CG, Vonk MC, Knaapen H, van den Berg W, Dalm VA, Van Daele PL, Severino A, Maria NI, Guillen S, Dik WA, Beretta L, Versnel MA, Radstake T. Brkic Z, et al. Among authors: severino a. Ann Rheum Dis. 2016 Aug;75(8):1567-73. doi: 10.1136/annrheumdis-2015-207392. Epub 2015 Sep 14. Ann Rheum Dis. 2016. PMID: 26371289
An EULAR study group pilot study on reliability of simple capillaroscopic definitions to describe capillary morphology in rheumatic diseases.
Smith V, Beeckman S, Herrick AL, Decuman S, Deschepper E, De Keyser F, Distler O, Foeldvari I, Ingegnoli F, Müller-Ladner U, Riccieri V, Riemekasten G, Sulli A, Voskuyl A, Cutolo M; EULAR study group on microcirculation. Smith V, et al. Rheumatology (Oxford). 2016 May;55(5):883-90. doi: 10.1093/rheumatology/kev441. Epub 2016 Feb 3. Rheumatology (Oxford). 2016. PMID: 26843483
167 results